Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

[Folates in the treatment of depression].

Erbe S, Pellert UN.

Fortschr Neurol Psychiatr. 2014 Feb;82(2):78-83. doi: 10.1055/s-0033-1356123. Review. German.

PMID:
24519190
2.

The role of L-methylfolate in depressive disorders.

Farah A.

CNS Spectr. 2009 Jan;14(1 Suppl 2):2-7. Review.

PMID:
19169195
3.

No clear potentiation of antidepressant medication effects by folic acid+vitamin B12 in a large community sample.

Christensen H, Aiken A, Batterham PJ, Walker J, Mackinnon AJ, Fenech M, Hickie IB.

J Affect Disord. 2011 Apr;130(1-2):37-45. doi: 10.1016/j.jad.2010.07.029.

PMID:
20805005
4.

Augmenting antidepressants with folate: a clinical perspective.

Fava M.

J Clin Psychiatry. 2007;68 Suppl 10:4-7.

5.

Augmentation and combination strategies in treatment-resistant depression.

Fava M.

J Clin Psychiatry. 2001;62 Suppl 18:4-11. Review.

6.

L-methylfolate (Deplin) for depression.

[No authors listed]

Med Lett Drugs Ther. 2010 Apr 19;52(1336):31-2. No abstract available.

PMID:
20407417
7.

Folate and unipolar depression.

Morris DW, Trivedi MH, Rush AJ.

J Altern Complement Med. 2008 Apr;14(3):277-85. doi: 10.1089/acm.2007.0663. Review.

PMID:
18370582
8.

Folate augmentation of antidepressant response.

Owen RT.

Drugs Today (Barc). 2013 Dec;49(12):791-8. doi: 10.1358/dot.2013.49.12.2086138. Review.

PMID:
24524097
9.

The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life.

Ford AH, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida OP.

Trials. 2010 Jan 25;11:8. doi: 10.1186/1745-6215-11-8. Erratum in: Trials. 2011;12:193.

10.
11.

Folate augmentation of treatment - evaluation for depression (FolATED): protocol of a randomised controlled trial.

Roberts SH, Bedson E, Hughes D, Lloyd K, Menkes DB, Moat S, Pirmohamed M, Slegg G, Thome J, Tranter R, Whitaker R, Wilkinson C, Russell I.

BMC Psychiatry. 2007 Nov 15;7:65. Erratum in: BMC Psychiatry. 2009;9. doi: 10.1186/1471-244X-9-14. Menkes, David B [added]; Thome, Johannes [added].

12.
13.

Beyond the resistance: how novel neurobiological understandings of depression may lead to advanced treatment strategies.

Jain R, Jackson WC.

J Clin Psychiatry. 2012 Nov;73(11):e30. doi: 10.4088/JCP.12020wc3.

14.

Using adjunctive treatments when first-line antidepressants fail.

Thase ME.

J Clin Psychiatry. 2012 Jan;73(1):e01. doi: 10.4088/JCP.10126tx4c.

15.

Treatment resistant depression: strategies for primary care.

Preston TC, Shelton RC.

Curr Psychiatry Rep. 2013 Jul;15(7):370. doi: 10.1007/s11920-013-0370-7. Review.

PMID:
23712721
16.

Enhancement of recovery from psychiatric illness by methylfolate.

Procter A.

Br J Psychiatry. 1991 Aug;159:271-2.

PMID:
1773245
17.

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA.

J Affect Disord. 2013 Oct;151(1):209-19. doi: 10.1016/j.jad.2013.05.079.

PMID:
23810357
18.

Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.

Friedman ES, Davis LL, Zisook S, Wisniewski SR, Trivedi MH, Fava M, Rush AJ; CO-MED Study Team..

Eur Neuropsychopharmacol. 2012 Mar;22(3):183-99. doi: 10.1016/j.euroneuro.2011.07.010.

19.

Folate and depression--a neglected problem.

Young SN.

J Psychiatry Neurosci. 2007 Mar;32(2):80-2. No abstract available.

20.

[Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response].

Sun XY, Zhang ZJ, Shi YY, Xu Z, Pu MJ, Geng LY.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Feb;30(1):26-30. doi: 10.3760/cma.j.issn.1003-9406.2013.01.007. Chinese.

PMID:
23450474
Items per page

Supplemental Content

Support Center